| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/10/2002 | CN1087346C RANTFS peptide and fragments for treatment of inflammation, and compositions with them |
| 07/10/2002 | CN1087344C Transforming growth factor alpha-H1 |
| 07/10/2002 | CN1087175C Vaccines raising immunological response against viruses causing porcing respiratory and reproductive diseases |
| 07/09/2002 | US6417336 Antibody against cleavage product or vimentin |
| 07/09/2002 | US6417334 Antagonists to chaperonin 10 |
| 07/09/2002 | US6417333 Modified human parathyroid hormone |
| 07/09/2002 | US6417331 Polypeptides |
| 07/09/2002 | US6417329 Purified polypeptide |
| 07/09/2002 | US6417328 Isolated genes encoding tumor necrosis factor-related apotosis-inducing ligand (trail) receptor splice variant cdna sequences, or active fragment; immunogens, modulation therapeutic autoimmune diseases, aids |
| 07/09/2002 | US6417327 Peptide capable of regulating physiological function of FGF-5 and pharmaceutical composition containing the peptide |
| 07/09/2002 | US6417158 Method of ameliorating the harmful effects of TNF using a polypeptide having the ability to bind to TNF |
| 07/09/2002 | US6416998 Polypeptides |
| 07/09/2002 | US6416997 Receptor-binding pocket mutants of influenza a virus hemagglutinin for use in targeted gene delivery |
| 07/09/2002 | US6416984 Human DNA mismatch repair proteins |
| 07/09/2002 | US6416976 TrpS |
| 07/09/2002 | US6416975 Human glycine transporter type 2 |
| 07/09/2002 | US6416974 Tango 71 nucleic acids |
| 07/09/2002 | US6416972 Purified hybrid nucleic acid |
| 07/09/2002 | US6416971 Soluble, single chain t cell receptor encoded by specified nucleic acid sequence |
| 07/09/2002 | US6416968 Methods of inhibiting Helicobacter pylori |
| 07/09/2002 | US6416956 Screening for and/or diagnosing breast cancer by obtaining cell sample from patient and determining whether bp1 is overexpressed by said cell sample as compared to normal cells |
| 07/09/2002 | US6416950 Linking nucleic acid reverse transcription primer which is bound to peptide acceptor to rna, translating rna to produce protein product covalently bound to primer, reverse transcribing rna to produce dna-protein fusion |
| 07/09/2002 | US6416758 Antibody conjugate kits for selectively inhibiting VEGF |
| 07/09/2002 | CA2133845C Adrenocorticotrophic hormone receptor and uses |
| 07/09/2002 | CA2077434C Antigenic proteins of borrelia burgdorferi |
| 07/09/2002 | CA2042236C Seroreactive epitopes on proteins of human papillomavirus (hpv) 18 |
| 07/09/2002 | CA2040707C Cephalosporin acetylhydrolase gene and protein encoded by said gene |
| 07/09/2002 | CA1341375C Compositions and methods for the treatment and prevention of gram-negative bacterial infections |
| 07/04/2002 | WO2002052029A1 Process for producing recombinant protein and fused protein |
| 07/04/2002 | WO2002052012A2 Sugar beet genes involved in stress tolerance |
| 07/04/2002 | WO2002052004A1 Gene involved in apoptosis regulation |
| 07/04/2002 | WO2002051998A1 Novel protease |
| 07/04/2002 | WO2002051871A2 Anti-cd28 antibody |
| 07/04/2002 | WO2002051868A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 07/04/2002 | WO2002051864A1 Protein cluster ii |
| 07/04/2002 | WO2002051231A1 Genes of corynebacterium |
| 07/04/2002 | WO2002026988A9 Human drug metabolizing enzymes |
| 07/04/2002 | WO2002023202A8 Method to identify antibody targets based on mass spectrometry (maldi-tof) |
| 07/04/2002 | WO2002012274A3 Iapl-3 a protein inhibitor of apoptosis proteins |
| 07/04/2002 | WO2002002624A3 B7-like molecules and uses thereof |
| 07/04/2002 | WO2002000677A8 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001090148A8 Neurotransmitter transporters |
| 07/04/2002 | WO2001077169A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 07/04/2002 | WO2001059089A3 Improved galactosylation of recombinant glycoproteins |
| 07/04/2002 | WO2001036589A9 Human ex vivo immune system |
| 07/04/2002 | WO2001034808A3 Method of large-scale production and method of testing of the biological activity of a substance from soybean |
| 07/04/2002 | WO2001032673A9 Sequences encoding human neoplastic marker |
| 07/04/2002 | WO2000069909A9 Isolation and characterization of epidermal growth factor related protein |
| 07/04/2002 | WO2000069891A9 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 07/04/2002 | WO2000022430A9 Neisseria genomic sequences and methods of their use |
| 07/04/2002 | US20020088027 Expression of biologically active polypeptides in duckweed |
| 07/04/2002 | US20020086987 Nucleotide sequence coding human protein for use in treatment of osteoporosis and bone disorders |
| 07/04/2002 | US20020086978 Specific binding agents |
| 07/04/2002 | US20020086973 Folding protein into wild type configuration; obtain culture, adjust ionic concentration, incubate with folding catalyst, centrifuge broth, oxidize supernatant, recover polypeptide |
| 07/04/2002 | US20020086845 Rat PTTG polypeptide and method for producing it |
| 07/04/2002 | US20020086827 RANK (receptor activator of neurotrophic factor-kappa B) polypeptides; immunoregulatory activity |
| 07/04/2002 | US20020086826 Antibodies against ligand for receptor activator of NF-kB |
| 07/04/2002 | US20020086823 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | US20020086822 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | US20020086821 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | US20020086820 Respiratory system related polynucleotides and polypeptides (antigens) for detection/diagnosis of cancer |
| 07/04/2002 | US20020086817 Mannan-binding protein or gene; vaccinia virus vectors |
| 07/04/2002 | US20020086811 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | US20020086403 Polypeptide for use in the treatment and prevention of viral infections and cancer |
| 07/04/2002 | US20020086385 Nucleotide sequences coding enzyymatic polypeptide for use in prevention of bacterial infection; bactericides |
| 07/04/2002 | US20020086379 Human membrane-spanning proteins |
| 07/04/2002 | US20020086362 Human amine receptor |
| 07/04/2002 | US20020086360 Polypeptide for use in treatment of congestive heart failure, ischaemic heart defects, arrhytmias, cardioiomyopathy and stroke |
| 07/04/2002 | US20020086359 Polypeptide for use in controlling signal transduction |
| 07/04/2002 | US20020086353 Nucleotide sequences coding polypeptides for use in the treatment of cancer, skin, immunological, nervous system, develpomental and cardiovascular disorders |
| 07/04/2002 | US20020086352 Methods for expressing endostatin protein |
| 07/04/2002 | US20020086350 Microbial swollenin protein, dna sequences encoding such swollenins and method of producing such swollenins |
| 07/04/2002 | US20020086330 Nucleotide sequences coding polypeptide for use in diagnosis, prevention and treatment of preferential urogenital disorders |
| 07/04/2002 | US20020086320 Detecting prostate cancer gene in test sample; obtain nucleotide sequence sample, incubate with probe, detect signal for from probes bound to target sequences |
| 07/04/2002 | US20020086316 Reagents and methods useful for detecting diseases of the prostate |
| 07/04/2002 | US20020086314 Nucleotide sequences coding polypeptides for use in the treatment of cancer |
| 07/04/2002 | US20020086305 Human c-Maf compositions and methods of use thereof |
| 07/04/2002 | US20020086297 Gene alteration in the gene for the Gbeta3-subunit of the human G protein |
| 07/04/2002 | US20020086025 Antibodies that bind to alpha2-antiplasmin crosslinked to fibrin which do not inhibit plasma alpha2-antiplasmin |
| 07/04/2002 | US20020086024 RatB polypeptides and DNA (RNA) encoding ratB polypeptides producing such polypeptides by recombinant techniques; utilizing ratB polypeptides to screen for antibacterial compounds. |
| 07/04/2002 | US20020086022 A target antigen is mixed with a heterologous antisera specific or cross-reactive to that antigen to produce an inoculant. |
| 07/04/2002 | US20020086008 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 07/04/2002 | DE10037759A1 Screeningverfahren Screening method |
| 07/04/2002 | CA2432716A1 Process for producing recombinant protein and fused protein |
| 07/04/2002 | CA2432380A1 Sugar beet genes involved in stress tolerance |
| 07/04/2002 | CA2432214A1 Gene involved in apoptosis regulation |
| 07/03/2002 | EP1219710A1 Novel polypeptides and genes encoding the same |
| 07/03/2002 | EP1219638A2 G-protein coupled receptors having homology to the P2Y purinoreceptor 1 (P2Y1) |
| 07/03/2002 | EP1219636A2 Modified muteins of erythropoietin (EPO) derived from in vitro or in vivo expression system of microorganisms |
| 07/03/2002 | EP1218538A2 Cancer associated antigens and uses therefor |
| 07/03/2002 | EP1218520A1 Checkpoint gene associated cell cycle proteins, compositions and methods of use |
| 07/03/2002 | EP1218519A1 Enzyme which cleaves ester groups and which is derived from thermomonospora fusca |
| 07/03/2002 | EP1218515A2 Regulation with binding cassette transporter protein abc1 |
| 07/03/2002 | EP1218509A2 Fibroblast growth factor-like polypeptides |
| 07/03/2002 | EP1218506A1 Traf4 associated cell cycle proteins, compositions and methods of use |
| 07/03/2002 | EP1218505A2 Syk kinase-associated cell cycle proteins, compositions and methods of use |
| 07/03/2002 | EP1218504A2 Gl50 molecules and uses therefor |
| 07/03/2002 | EP1218501A1 Creation of variable length and sequence linker regions for dual-domain or multi-domain molecules |
| 07/03/2002 | EP1218491A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 07/03/2002 | EP1218414A2 Polypeptides for detection and elimination of ca19-9 antigen positive cells |